KROS - Keros Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

KROS is currently covered by 5 analysts with an average price target of $86.23. This is a potential upside of $30.45 (54.59%) from yesterday's end of day stock price of $55.78.

Keros Therapeutics 's activity chart (see below) currently has 16 price targets and 27 ratings on display. The stock rating distribution of KROS is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.11% with an average time for these price targets to be met of 24.86 days.

Highest price target for KROS is $105, Lowest price target is $86, average price target is $86.23.

Most recent stock forecast was given by JOSEPH CATANZARO from PIPER SANDLER on 27-Mar-2024. First documented stock forecast 04-May-2020.

Currently out of the existing stock ratings of KROS, 17 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

105

$49.22 (88.24%)

110

28 days ago

5/11 (45.45%)

$40.34 (62.39%)

43

Buy

100

$44.22 (79.28%)

100

1 months 11 days ago

0/3 (0%)

$32.34 (47.80%)

Buy

100

$44.22 (79.28%)

100

1 months 23 days ago

1/7 (14.29%)

$31.15 (45.24%)

113

Buy

86

$30.22 (54.18%)

86

5 months 11 days ago

0/4 (0%)

$56.01 (186.76%)

Buy

105

$49.22 (88.24%)

80

1 years 4 months 11 days ago

0/2 (0%)

$53.23 (102.82%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KROS (Keros Therapeutics ) average time for price targets to be met?

On average it took 24.86 days on average for the stock forecasts to be realized with a an average price target met ratio 37.11

Which analyst has the current highest performing score on KROS (Keros Therapeutics ) with a proven track record?

JOSEPH CATANZARO

Which analyst has the current lower performing score on KROS (Keros Therapeutics ) with a proven track record?

SRIKRIPA DEVARAKONDA

Which analyst has the most public recommendations on KROS (Keros Therapeutics )?

Joseph Catanzaro works at PIPER SANDLER and has 9 price targets and 7 ratings on KROS

Which analyst is the currently most bullish on KROS (Keros Therapeutics )?

Julian Harrison with highest potential upside - $49.22

Which analyst is the currently most reserved on KROS (Keros Therapeutics )?

Tom Smith with lowest potential downside - $21.98

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?